APO Research
Talk to an analyst

APO RESEARCH · REPORT

Darunavir

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Darunavir Market Outlook and Growth Opportunities 2026

22 December 2025194 pages

Choose your research edition.

Industry ResearchDarunavir Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Darunavir Industry Growth and Trends Forecast to 203288 pages · $3,450 USDMarket StructureGlobal Darunavir Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Darunavir Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Darunavir Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Darunavir market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Darunavir is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Darunavir is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Darunavir is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Darunavir market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Darunavir market include Janssen Therapeutics, Teva, Mylan, Lupin, Hetero and Cipla, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Darunavir market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Darunavir and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Darunavir revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Darunavir market.

Darunavir Segment by Company

Janssen Therapeutics

Teva

Mylan

Lupin

Hetero

Cipla

Darunavir Segment by Type

Tablet

Oral suspension

Darunavir Segment by Application

Hospital

Drug store

Darunavir Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Darunavir status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Darunavir key companies, revenue, market share, and recent developments.

3. To split the Darunavir breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Darunavir market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Darunavir significant trends, drivers, influence factors in global and regions.

6. To analyze Darunavir competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Darunavir market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Darunavir and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Darunavir.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Darunavir industry.

Chapter 3: Detailed analysis of Darunavir company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Darunavir in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Darunavir in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Darunavir Industry Trends Table 2. Darunavir Industry Drivers Table 3. Darunavir Industry Opportunities and Challenges Table 4. Darunavir Industry Restraints Table 5. Global Darunavir Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Darunavir Revenue Share by Company (2021-2026) Table 7. Global Darunavir Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Darunavir Key Company Manufacturing Base & Headquarters Table 9. Global Darunavir Company, Product Type & Application Table 10. Global Darunavir Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Darunavir by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Tablet Table 15. Significant Companies of Oral suspension Table 16. Global Darunavir Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Darunavir Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Darunavir Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Darunavir Sales Value Share by Type (2021-2026) Table 20. Global Darunavir Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Hospital Table 22. Significant Companies of Drug store Table 23. Global Darunavir Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 24. Global Darunavir Sales Value by Application (2021-2026) & (US$ Million) Table 25. Global Darunavir Sales Value by Application (2027-2032) & (US$ Million) Table 26. Global Darunavir Sales Value Share by Application (2021-2026) Table 27. Global Darunavir Sales Value Share by Application (2027-2032) Table 28. Global Darunavir Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Darunavir Sales Value by Region (2021-2026) & (US$ Million) Table 30. Global Darunavir Sales Value Share by Region (2021-2026) Table 31. Global Darunavir Sales Value by Region (2027-2032) & (US$ Million) Table 32. Global Darunavir Sales Value Share by Region (2027-2032) Table 33. Global Darunavir Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Darunavir Sales Value by Country (2021-2026) & (US$ Million) Table 35. Global Darunavir Sales Value Market Share by Country (2021-2026) Table 36. Global Darunavir Sales Value by Country (2027-2032) & (US$ Million) Table 37. Global Darunavir Sales Value Market Share by Country (2027-2032) Table 38. Janssen Therapeutics Company Information Table 39. Janssen Therapeutics Business Overview Table 40. Janssen Therapeutics Darunavir Revenue (US$ Million) and Gross Margin (2021-2026) Table 41. Janssen Therapeutics Darunavir Product Portfolio Table 42. Janssen Therapeutics Recent Development Table 43. Teva Company Information Table 44. Teva Business Overview Table 45. Teva Darunavir Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Teva Darunavir Product Portfolio Table 47. Teva Recent Development Table 48. Mylan Company Information Table 49. Mylan Business Overview Table 50. Mylan Darunavir Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Mylan Darunavir Product Portfolio Table 52. Mylan Recent Development Table 53. Lupin Company Information Table 54. Lupin Business Overview Table 55. Lupin Darunavir Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Lupin Darunavir Product Portfolio Table 57. Lupin Recent Development Table 58. Hetero Company Information Table 59. Hetero Business Overview Table 60. Hetero Darunavir Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Hetero Darunavir Product Portfolio Table 62. Hetero Recent Development Table 63. Cipla Company Information Table 64. Cipla Business Overview Table 65. Cipla Darunavir Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Cipla Darunavir Product Portfolio Table 67. Cipla Recent Development Table 68. Research Programs/Design for This Report Table 69. Authors List of This Report Table 70. Secondary Sources Table 71. Primary Sources List of Figures Figure 1. Darunavir Product Image Figure 2. Global Darunavir Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Darunavir Market Size (2021-2032) & (US$ Million) Figure 4. Global Darunavir Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Tablet Image Figure 8. Oral suspension Image Figure 9. Global Darunavir Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Darunavir Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Darunavir Sales Value Share by Type (2021-2032) Figure 12. Hospital Image Figure 13. Drug store Image Figure 14. Global Darunavir Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Darunavir Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Darunavir Sales Value Share by Application (2021-2032) Figure 17. Global Darunavir Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Darunavir Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 19. North America Darunavir Sales Value (2021-2032) & (US$ Million) Figure 20. North America Darunavir Sales Value Share by Country (%), 2025 VS 2032 Figure 21. Europe Darunavir Sales Value (2021-2032) & (US$ Million) Figure 22. Europe Darunavir Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Asia-Pacific Darunavir Sales Value (2021-2032) & (US$ Million) Figure 24. Asia-Pacific Darunavir Sales Value Share by Country (%), 2025 VS 2032 Figure 25. South America Darunavir Sales Value (2021-2032) & (US$ Million) Figure 26. South America Darunavir Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Middle East & Africa Darunavir Sales Value (2021-2032) & (US$ Million) Figure 28. Middle East & Africa Darunavir Sales Value Share by Country (%), 2025 VS 2032 Figure 29. USA Darunavir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 30. USA Darunavir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 31. USA Darunavir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 32. Canada Darunavir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. Canada Darunavir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. Canada Darunavir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Mexico Darunavir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Mexico Darunavir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Mexico Darunavir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Germany Darunavir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Germany Darunavir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Germany Darunavir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. France Darunavir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. France Darunavir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. France Darunavir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. U.K. Darunavir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. U.K. Darunavir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. U.K. Darunavir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Italy Darunavir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Italy Darunavir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Italy Darunavir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Spain Darunavir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Spain Darunavir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Spain Darunavir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Russia Darunavir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Russia Darunavir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Russia Darunavir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Netherlands Darunavir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Netherlands Darunavir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Netherlands Darunavir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Nordic Countries Darunavir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Nordic Countries Darunavir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Nordic Countries Darunavir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. China Darunavir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. China Darunavir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. China Darunavir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Japan Darunavir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Japan Darunavir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Japan Darunavir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. South Korea Darunavir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. South Korea Darunavir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. South Korea Darunavir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. India Darunavir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. India Darunavir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. India Darunavir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Australia Darunavir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Australia Darunavir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Australia Darunavir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Southeast Asia Darunavir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Southeast Asia Darunavir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Southeast Asia Darunavir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Brazil Darunavir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Brazil Darunavir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Brazil Darunavir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Argentina Darunavir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Argentina Darunavir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Argentina Darunavir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Chile Darunavir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Chile Darunavir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Chile Darunavir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Colombia Darunavir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Colombia Darunavir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Colombia Darunavir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Peru Darunavir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Peru Darunavir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Peru Darunavir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Saudi Arabia Darunavir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Saudi Arabia Darunavir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Darunavir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Israel Darunavir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Israel Darunavir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Israel Darunavir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. UAE Darunavir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. UAE Darunavir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. UAE Darunavir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Turkey Darunavir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Turkey Darunavir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Turkey Darunavir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Iran Darunavir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Iran Darunavir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Iran Darunavir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Egypt Darunavir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Egypt Darunavir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Egypt Darunavir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Years Considered Figure 114. Research Process Figure 115. Key Executives Interviewed

Scope & coverage.

Types
  • Tablet
  • Oral suspension
Applications
  • Hospital
  • Drug store
Companies covered
  • Janssen Therapeutics
  • Teva
  • Mylan
  • Lupin
  • Hetero
  • Cipla

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Darunavir Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Darunavir Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Darunavir Market Dynamics
  1. 2.1 Darunavir Industry Trends
  2. 2.2 Darunavir Industry Drivers
  3. 2.3 Darunavir Industry Opportunities and Challenges
  4. 2.4 Darunavir Industry Restraints
3 Darunavir Market by Company
  1. 3.1 Global Darunavir Company Revenue Ranking in 2025
  2. 3.2 Global Darunavir Revenue by Company (2021-2026)
  3. 3.3 Global Darunavir Company Ranking (2024-2026)
  4. 3.4 Global Darunavir Company Manufacturing Base and Headquarters
  5. 3.5 Global Darunavir Company Product Type and Application
  6. 3.6 Global Darunavir Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Darunavir Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Darunavir Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Darunavir Market by Type
  1. 4.1 Darunavir Type Introduction
  2. 4.1.1 Tablet
  3. 4.1.2 Oral suspension
  4. 4.2 Global Darunavir Sales Value by Type
  5. 4.2.1 Global Darunavir Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Darunavir Sales Value by Type (2021-2032)
  7. 4.2.3 Global Darunavir Sales Value Share by Type (2021-2032)
5 Darunavir Market by Application
  1. 5.1 Darunavir Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Drug store
  4. 5.2 Global Darunavir Sales Value by Application
  5. 5.2.1 Global Darunavir Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Darunavir Sales Value by Application (2021-2032)
  7. 5.2.3 Global Darunavir Sales Value Share by Application (2021-2032)
6 Darunavir Regional Value Analysis
  1. 6.1 Global Darunavir Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Darunavir Sales Value by Region (2021-2032)
  3. 6.2.1 Global Darunavir Sales Value by Region: 2021-2026
  4. 6.2.2 Global Darunavir Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Darunavir Sales Value (2021-2032)
  7. 6.3.2 North America Darunavir Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Darunavir Sales Value (2021-2032)
  10. 6.4.2 Europe Darunavir Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Darunavir Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Darunavir Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Darunavir Sales Value (2021-2032)
  16. 6.6.2 South America Darunavir Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Darunavir Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Darunavir Sales Value Share by Country, 2025 VS 2032
7 Darunavir Country-level Value Analysis
  1. 7.1 Global Darunavir Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Darunavir Sales Value by Country (2021-2032)
  3. 7.2.1 Global Darunavir Sales Value by Country (2021-2026)
  4. 7.2.2 Global Darunavir Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Darunavir Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Darunavir Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Darunavir Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Darunavir Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Darunavir Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Darunavir Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Darunavir Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Darunavir Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Darunavir Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Darunavir Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Darunavir Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Darunavir Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Darunavir Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Darunavir Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Darunavir Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Darunavir Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Darunavir Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Darunavir Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Darunavir Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Darunavir Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Darunavir Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Darunavir Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Darunavir Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Darunavir Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Darunavir Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Darunavir Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Darunavir Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Darunavir Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Darunavir Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Darunavir Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Darunavir Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Darunavir Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Darunavir Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Darunavir Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Darunavir Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Darunavir Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Darunavir Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Darunavir Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Darunavir Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Darunavir Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Darunavir Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Darunavir Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Darunavir Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Darunavir Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Darunavir Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Darunavir Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Darunavir Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Darunavir Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Darunavir Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Darunavir Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Darunavir Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Darunavir Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Darunavir Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Darunavir Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Darunavir Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Darunavir Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Darunavir Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Darunavir Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Darunavir Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Darunavir Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Darunavir Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Darunavir Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Darunavir Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Darunavir Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Darunavir Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Darunavir Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Darunavir Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Darunavir Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Darunavir Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Darunavir Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Darunavir Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Darunavir Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Darunavir Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Darunavir Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Darunavir Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Darunavir Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Darunavir Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Darunavir Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Darunavir Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Darunavir Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Darunavir Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Darunavir Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Darunavir Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Darunavir Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Janssen Therapeutics
  2. 8.1.1 Janssen Therapeutics Company Information
  3. 8.1.2 Janssen Therapeutics Business Overview
  4. 8.1.3 Janssen Therapeutics Darunavir Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Janssen Therapeutics Darunavir Product Portfolio
  6. 8.1.5 Janssen Therapeutics Recent Developments
  7. 8.2 Teva
  8. 8.2.1 Teva Company Information
  9. 8.2.2 Teva Business Overview
  10. 8.2.3 Teva Darunavir Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Teva Darunavir Product Portfolio
  12. 8.2.5 Teva Recent Developments
  13. 8.3 Mylan
  14. 8.3.1 Mylan Company Information
  15. 8.3.2 Mylan Business Overview
  16. 8.3.3 Mylan Darunavir Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Mylan Darunavir Product Portfolio
  18. 8.3.5 Mylan Recent Developments
  19. 8.4 Lupin
  20. 8.4.1 Lupin Company Information
  21. 8.4.2 Lupin Business Overview
  22. 8.4.3 Lupin Darunavir Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Lupin Darunavir Product Portfolio
  24. 8.4.5 Lupin Recent Developments
  25. 8.5 Hetero
  26. 8.5.1 Hetero Company Information
  27. 8.5.2 Hetero Business Overview
  28. 8.5.3 Hetero Darunavir Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Hetero Darunavir Product Portfolio
  30. 8.5.5 Hetero Recent Developments
  31. 8.6 Cipla
  32. 8.6.1 Cipla Company Information
  33. 8.6.2 Cipla Business Overview
  34. 8.6.3 Cipla Darunavir Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Cipla Darunavir Product Portfolio
  36. 8.6.5 Cipla Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst